GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Avanir Pharmaceuticals (AVNR) [hlAlert]

Avanir Pharmaceuticals is a pharmaceutical company focused on developing, acquiring and commercializing therapeutic products for the treatment of chronic diseases. The Company?s product candidates address therapeutic markets that include the central nervous system and inflammatory
diseases. Its principal product candidate, Zenviatm (dextromethorphan hydrobromide/quinidine sulfate), is in Phase III clinical development for the treatment of pseudobulbar affect (PBA) and diabetic peripheral neuropathic pain (DPN pain). The Company?s first commercialized product, docosanol 10% cream, (sold as Abreva by its marketing partner GlaxoSmithKline Consumer Healthcare in North America) is an over-the-counter treatment for cold sores that has been approved by the United States Food and Drug Administration (FDA).
.
( Total: 12 Current Stock Recommendations )
Avanir Pharmaceuticals   (12)
Sell Hold 17% Buy 75%
Related companies
China Biologic ...   (4)
Buy 100%
Opko Health Inc   (2)
Buy 100%
Talecris ...   (4)
Buy 100%
Anacor ...   (6)
Buy 100%
Santarus, Inc.   (13)
Hold 31% Buy 69%
Cardinal Health, ...   (24)
Hold 29% Buy 71%
Incyte Corporation   (22)
Sell Hold Buy 82%
Nbty, Inc.   (9)
Hold 44% Buy 56%
Dr. Reddy's ...   (5)
Sell 20% Hold 40% Buy 40%
Salix ...   (31)
Hold 39% Buy 61%
Show  

Date (ET)MemberRatingYTD
Gains
 
8/9/2007  
Sell
  
1/26/2009  
Hold
  
1/29/2010  
Buy
  
4/6/2010  
Buy
  
7/1/2010  
Buy
  
10/7/2010  
Buy
  
11/2/2010  
Buy
  
8/23/2011  
Buy
  
1/20/2012  
Buy
  
1/4/2013  
Buy
  
7/8/2013  
Buy
  
12/11/2013  
Hold
  

* As of 8/27/2015 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy